Table 2.
Mean serum ALP levels of subjects with fibrous dysplasia, ossifying fibroma and osseous dysplasia at presentation, and at the 3rd and 6th month post-treatment
| Tumour type | n | Subjects with elevated serum ALP at presentation n (%) |
Mean serum ALP ± SD at presentation (IU/L) | Mean serum ALP ± SD at 3 months (IU/L) | Mean serum ALP ± SD at 6 months (IU/L) |
|---|---|---|---|---|---|
| Fibrous dysplasia | 32 | 10 (31.3) | 402 ± 212.1 | 297.6±191.2 | 294.8 ± 194 |
| Ossifying fibroma | 17 | 1 (5.9) | 233.4 ± 111.7 | 153.1 ± 50.6 | 146 ± 43.2 |
| Osseous dysplasia | 1 | 0 | 231 | 127 | 109 |
| Total | 50 | 11(22) | 341.2 ± 198.1 | 245 ± 170.2 | 240.5 ± 172.7 |